Join
Live feed
·
PRReleasevia Quantisnow
Erasca Inc. logo
Novartis AG logo

Erasca Announces Exclusive Worldwide License for Pan-RAF Inhibitor Naporafenib

ByQuantisnow·Wall Street's wire, on your screen.
ERAS· Erasca Inc.NVS· Novartis AG
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ERAS (Erasca Inc.), NVS (Novartis AG) and more on Quantisnow.